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Abstract
No unique transcription factor or biomarker has been identified to reliably distinguish effector from memory T cells. Instead
a set of surface markers including IL-7Ra and KLRG1 is commonly used to predict the potential of CD8 effector T cells to
differentiate into memory cells. Similarly, these surface markers together with the tumor necrosis factor family member
CD27 are frequently used to predict a memory T cell’s ability to mount a recall response. Expression of these markers
changes every time a memory cell is stimulated and repeated stimulation can lead to T cell senescence and loss of memory
T cell responsiveness. This is a concern for prime–boost vaccine strategies which repeatedly stimulate T cells with the aim of
increasing memory T cell frequency. The molecular cues that cause senescence are still unknown, but cell division history is
likely to play a major role. We sought to dissect the roles of inflammation and cell division history in developing T cell
senescence and their impact on the expression pattern of commonly used markers of senescence. We developed a system
that allows priming of CD8 T cells with minimal inflammation and without acquisition of maximal effector function, such as
granzyme expression, but a cell division history similar to priming with systemic inflammation. Memory cells derived from
minimal effector T cells are fully functional upon rechallenge, have full access to non-lymphoid tissue and appear to be less
senescent by phenotype upon rechallenge. However, we report here that these currently used biomarkers to measure
senescence do not predict proliferative potential or protective ability, but merely reflect initial priming conditions.
Citation: Prlic M, Sacks JA, Bevan MJ (2012) Dissociating Markers of Senescence and Protective Ability in Memory T Cells. PLoS ONE 7(3): e32576. doi:10.1371/
journal.pone.0032576
Editor: Ryan M. Teague, Saint Louis University School of Medicine, United States of America
Received November 22, 2011; Accepted January 27, 2012; Published March 2, 2012
Copyright:  2012 Prlic et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health grants AI 019335 (to MJB) and AI 079159 (to MP) and the Howard Hughes Medical Institute (to
MJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mprlic@fhcrc.org (MP); mbevan@u.washington.edu (MJB)
¤a Current address: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
¤b Current address: Laboratory of Mycobacterial Immunity and Pathogenesis, The Public Health Research Institute at the University of Medicine and Dentistry of
New Jersey, Newark, New Jersey, United States of America
Introduction
Immunization drives proliferation and differentiation of effector
CD8 T cells followed by a contraction phase after the peak of the
T cell response [1,2]. The survivors of this contraction phase go on
to differentiate into long-lived memory cells, which can provide
life-long protection [3]. Identifying these memory cells early on in
a T cell response has been challenging due to the lack of a unique
marker. Instead, the expression pattern of the molecules IL-7Ra
and KLRG1 has been used to predict memory potential [4,5].
Activated CD8 T cells that express high levels of IL-7Ra and low
levels of KLRG1 are more likely to differentiate into memory cells
than cells with a different expression pattern [5]. This trend holds
true in several infectious disease mouse model systems including
lymphocytic choriomeningitis virus (LCMV), Listeria monocytogenes
(LM) and vesicular stomatitis virus (VSV), but not others such as
influenza [6]. Following influenza infection, CD8 effector T cells
express little KLRG1, but have normal contraction and memory
formation characteristics [6]. KLRG1 deficient CD8 T cells are
neither impaired nor enhanced in their ability to form memory
following infection with LCMV or VSV [7]. Together these data
demonstrate that KRLG1 expression is neither necessary nor
sufficient for T cell contraction and memory formation. Similarly,
IL-7Ra signaling is not sufficient to rescue activated T cells from
cell death during the contraction phase [8,9] and cells with little
IL-7Ra expression on the cell surface can still differentiate into
memory cells [4,5,10]. CD8 T cells that lack the pro-apoptotic
BH3 family member Bim do not undergo apoptosis during the
contraction phase, but Bim-deficient CD8 memory T cells are
fully functional regardless of their IL-7Ra and KLRG1 phenotype
during the priming phase suggesting that expression of these
markers is not linked to memory cell function [10]. Thus, the
currently used markers merely correlate with memory develop-
ment in some, but not all models of infectious disease and do not
play a decisive functional role in memory cell development. A
similar set of markers is used to predict the proliferative potential
of memory cells, typically based on KLRG1 and CD27 expression
levels. Low levels of KLRG1 expression combined with high
expression levels of the TNF family member CD27 have been
reported to be hallmarks for fit memory cells [11]. Senescent
memory cells that have lost proliferative potential have been
reported to express low amounts of CD27 and high levels of
KLRG1 [11,12,13,14,15]. The degree of memory cell senescence
can increase with each round of memory T cell restimulation [12].
Thus, increasing the size of the memory pool by iterative
stimulation comes with the potential caveat that boosting the size
of the memory T cell pool could lead to T cell senescence and loss
of responsiveness [12,16,17].
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32576It is unclear whether cell division history dictates CD27 and
KLRG1 expression. Even if it did, how could CD27 and KLRG1
regulate memory T cell fitness? CD27 has co-stimulatory
properties and hence higher expression on the cell surface could
be beneficial for memory cells [15]. Such a beneficial effect has
been demonstrated for CD27
+ CD8 T cells in HIV-infected
Figure 1. CD8 T cells do not express effector markers when inflammation is limited. C57BL/6 mice were injected intravenously (i.v.) with
1610
6 peptide pulsed DCs and 1610
4 naı ¨ve OT-I T cells (Thy1.1) with (top, DC+LM) or without (bottom, DC only) an accompanying i.v. Listeria
monocytogenes (LM) infection. (A) OT-I T cell surface phenotype (IL-7Ra, KLRG-1, CD62L, CD27), (B) function (IL-2, IFNc and Tbet expression) and (C)
cytolytic potential (granzyme A and B) were determined 5 days post priming. Naı ¨ve polyclonal CD8 T cells are included as a baseline reference
(bottom panel). (D) The number of OT-I T cells in the spleen on day 5 post priming was calculated. (E) OT-I T cell abundance in the lung was
determined on day 5 post infection. The data shown are representative of up to 10 (and at least 2) independent experiments with 2–5 animals per
group.
doi:10.1371/journal.pone.0032576.g001
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CD8 T cells with low affinity for antigen to reach the effector and
memory stage [19], while T cells with high antigen affinity are
hardly dependent on CD27 expression. These data seem to rule
out a comprehensive role of CD27 in regulating memory cell
fitness. The connection between KLRG1 and senescence is also
unclear. Given that its ligand is unknown and KLRG1 knock-out
mice have no discernible phenotype [7], it is hard to hypothesize
how KLRG1 expression might affect memory T cell function.
We considered that the expression pattern of CD27 and
KLRG1 in memory cell populations does not reflect functional
properties and is instead simply a consequence of being exposed to
varying degrees of inflammation. We further speculated that the
expression levels of CD27 and KLRG1 at the memory stage are
not simply dictated by division history as currently postulated, but
directly linked to exposure to inflammation during the primary
response. Thus, we sought to establish a system that would allow
us to generate effector T cells with similar division history in the
context of different inflammatory environments (while keeping
other variables such as antigen availability constant) and
determine its impact on memory T cell formation, function and
senscence. To test our hypothesis we varied the amount of
inflammation by using antigen presenting activated dendritic cells
(DCs) either alone or accompanied by a bystander infection with
Listeria monocytogenes (LM) [20]. We report here that the protective
ability and proliferative potential of memory T cells did not
correlate with the currently used markers KLRG1 and CD27.
Rather, we found that CD27 and KLRG1 expression patterns
reflect the initial priming conditions of a T cell and are maintained
following a tertiary and quaternary memory response. Thus,
KLRG1 and CD27 expression patterns should not be used to
predict memory development or fitness, but can inform initial
priming conditions.
Results
We transferred low numbers of naı ¨ve, congenically marked OT-
I T cells and peptide-pulsed, LPS activated DCs into B6 hosts.
Half of the animals also received a priming dose of LM. Mice from
both the ‘‘DC only’’ group and the ‘‘DC+LM’’ group were
sacrificed at the peak of the response (day 5) and the OT-I T cell
response was analyzed. We found that OT-I T cells in both
experimental groups proliferated extensively, but found consis-
tently higher numbers of cells in the ‘‘DC+LM’’ group (Fig. 1A,
D), which was expected based on previous studies showing that
inflammation drives T cell proliferation [21,22]. OT-I T cells that
were primed in the absence of systemic inflammation (‘‘DC only’’
group) did not upregulate KLRG1 (Fig. 1A). In both experimental
conditions, IL-7Ra and CD62L surface expression were down-
regulated, although to a lesser extent in the ‘‘DC only’’ group
compared to the ‘‘DC+LM’’ group (Fig. 1A and data not shown).
OT-I T cells from both experimental groups produced IFNc,
indicating that priming was successful in both cases, although cells
from the ‘‘DC only’’ group made slightly less IFNc than those
from the ‘‘DC+LM’’ group (Fig. 1B). OT-I effector cells from both
groups had a similarly sized population of IFNc, IL-2 double
producing cells (Fig. 1B), arguing against the possibility that the
‘‘DC only’’ primed OT-I T cells are early memory cells that can
be generated in certain experimental conditions [23].
We found that OT-I T cells in both experimental groups
expressed T-bet on day 4 (data not shown) and 5 (Fig. 1B) post
activation. Expression of this transcription factor is required for
optimal CD8 T cell cytolytic function and IFNc production [24].
It has been previously shown that acquisition of cytolytic effector
function and cytokine production are not necessarily directly
linked events [25,26]. OT-I T cells that were primed in an LM
infected mouse expressed slightly higher levels of T-bet (Fig. 1B,
right hand panels), consistent with the following phenotype: only
OT-I T cells from the ‘‘DC+LM’’ group expressed granzyme A or
B (Fig. 1C). This inflammation-dependent difference in granzyme
expression was expected since inflammation is required for
optimal development of CD8 effector function, while IL-2 plays
a modest role [27,28,29,30]. Although the level of granzyme
expression appears to correlate with the number of cell divisions
[31] and OT-I T cells from the ‘‘DC only’’ group proliferated
slightly less, we wanted to address the possibility that granzyme
might be expressed earlier or later. We determined granzyme
expression on days 4 and 6 with the same results (data not shown).
At the peak of the primary response, there were approximately 36
more OT-I effector cells in the ‘‘DC+LM’’ group compared to the
‘‘DC only’’ group (Fig. 1D) indicating that cells in the ‘‘DC+LM’’
group did undergo 1 to 2 more rounds of cell division assuming a
similar extent of cell death between the two groups during
expansion. Together, these data demonstrate that we successfully
generated 2 sets of effector cells with comparable division history:
maximal effectors that express high levels of T-bet, KLRG1 and
granzymes (DC+LM) and minimal effectors that do not (DC only).
We investigated a possible link between granzyme expression
and programmed cell death during the contraction phase. We
found that OT-I T cells in both groups contracted equally (Fig. 2A,
B, E), showing that we generated bona fide effector cells in both
groups and that acquisition of effector markers and contraction are
not linked events. Next, we determined whether acquisition of
cytolytic effector markers affected the functionality of the T cell
pool after the contraction phase (day 14). Similar to what we had
observed on day 5, OT-I T cells from the ‘‘DC+LM’’ group
produced more IFNc upon in vitro restimulation (Fig. 2A).
Together, these data suggest that the expression patterns of
KLRG-1 and T-bet during the expansion phase do not necessarily
directly correlate with T cell fate in the contraction phase [32], but
are rather context and model dependent.
We considered the possibility that acquisition of maximal
effector function during the primary response might affect memory
cell homeostasis and function over time. We found that memory
cells (day 40+) from both groups were stably maintained over time
(Fig. 2D, E). Thus, OT-I T cell numbers in the ‘‘DC+LM’’ group
were about 3 to 4-fold higher compared to the ‘‘DC only’’ groups
at all time points measured (Fig. 2E). Memory cells of both groups
responded in an in vitro restimulation assay and the percentage of
IFNc producers was still reduced in the ‘‘DC only’’ group, while
the percentage of IL-2, IFNc double producers was similar
(Fig. 2C). Taken together, these data demonstrate that acquisition
of markers of effector function is not linked to memory
homeostasis and minimal effectors can give rise to a fit memory
population.
To assess whether memory T cells generated from maximal
effector and minimal effector cells are capable of mounting a
robust recall response, we directly challenged the memory mice
with a recombinant vaccinia strain (Vacc-OVA) on day 40 or later
after the initial priming. 5 days after the rechallenge, we sacrificed
the mice and analyzed T cell function and expansion (Fig. 3A, B).
OT-I T cells from both experimental groups proliferated in
response to the rechallenge and expressed granzyme B, as well as
IFNc (Fig. 3A). To better quantify the ability of memory cells from
each group to proliferate in response to rechallenge without the
limitation of having different memory precursor frequencies, we
isolated memory cells from both groups and transferred 500 OT-I
memory cells from ‘‘DC only’’ or ‘‘DC+LM’’ immunized mice
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T cell populations expanded more than 3610
4 fold (assuming a
10% take of the transferred cells [20]) during the secondary
response, equivalent to 15+ rounds of cell division (Fig. 3C).
Secondary effector cells from both experimental groups expressed
similar amounts of granzyme B and IFNc after rechallenge
(Fig. 3D). Our current data show that acquisition of maximal
effector function in the primary response is not necessary to
generate fully functional memory cells.
In addition to determining T cell number and function in the
spleen, we examined the ability of maximal and minimal effector
cells to migrate to and accumulate in non-lymphoid tissue. OT-I T
cells from both groups migrated to non lymphoid tissue, such as
the lung during the primary response (Fig. 1E), but maximal
effector OT-I T cells accumulated more, consistent with a more
pronounced decrease in CD62L expression levels (Fig. 1A). Upon
rechallenge, memory cells from both groups had a comparable
increase in numbers of OT-I cells in the lungs (Fig. 3E), similarly
to what was found in the spleen. Therefore acquisition of maximal
effector function in the primary response does not affect the ability
of memory cells to accumulate efficiently in non-lymphoid tissue in
a recall response.
Finally, we created tertiary memory cells from both groups by
following the priming stimulus with the same rechallenge stimulus
at least 30 days later (i.e. repeat ‘‘DC only’’ or ‘‘DC+LM’’), then
boosted the animals with VSV-OVA before transferring 1610
5 of
these memory cells into new hosts to examine their proliferative
potential and ability to clear a vaccinia infection. Before transfer,
the tertiary memory cells from both groups had an effector
memory phenotype and had uniformly low expression of CD62L
though they differed in CD27 and KLRG1 expression (Fig. 4A).
We observed the same phenotypic differences (minimal effectors
express less KLRG1 and more CD27) post-challenge with vaccinia
(Fig. 4B), but found no difference in the ability to expand or clear
virus (Fig. 4C, data not shown). Our data suggest that the initial
priming conditions control the phenotype of a memory cell,
including biomarkers that have been used to predict memory cell
fitness (CD27, KLRG1), but do not control proliferative potential
or protective ability.
Discussion
We sought to determine the relationship between inflammation,
cell division history and T cell senescence with its currently
associated biomarkers KLRG1 and CD27 in memory T cells. We
developed an experimental system that allowed us to regulate the
extent of inflammation, while keeping other variables, such as
antigen availability constant. This was achieved by transferring
LPS matured, peptide pulsed DCs in the presence (high
inflammation) or absence (low inflammation) of a bystander
Listeria monocytogenes infection. Infection with LM leads to the
generation of an IL-12 dominated inflammatory environment. IL-
Figure 2. CD8 effector cells contract and are maintained as
memory cells regardless of granzyme expression in the
primary response. (A) OT-I T cell function (IL-2, IFNc) and (B)
abundance (displayed as percent of total CD8 T cells in spleen) were
determined on day 14 post priming with peptide-pulsed DCs with (top,
DC+LM) or without (bottom, DC only) a Listeria infection. (C) Function
and (D) abundance were assessed in the spleen on day 40 or later after
priming. (E) The ratio of OT-I T cells in the DC+LM versus the DC only
group is plotted for the peak of the response (day 5), after the
contraction phase (day 14) and during the memory phase (day 40 or
later). The data are representative of at least 2 independent
experiments with 2–5 animals per group.
doi:10.1371/journal.pone.0032576.g002
Priming Stimuli Set Memory Phenotype Not Function
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leads to acquisition of effector function [33,34,35]. Priming naı ¨ve
CD8 T cells in conditions of low and high inflammation led to the
generation of minimal effectors expressing low levels and maximal
effectors expressing high levels of T-bet, KLRG1 and granzymes
A and B, respectively. Both effector populations had a similar
division history, but differed in their degree of effector function
acquisition (Fig. 1B, C). Both effector populations underwent
contraction to the same extent (Fig. 2A, B, E), although minimal
effectors expressed uniformly low levels of KLRG1 and high levels
of IL-7Ra (Fig. 1A). A similar phenotype has been previously
reported for effector cells that were primed in a low inflammation
setting [36]. KLRG1 expression levels directly correlated and IL-
7Ra expression levels inversely correlated with the degree of
inflammation present during priming (Fig. 1A). We found that
both ensuing memory populations were maintained equally well
(Fig. 2E) and responded equally well to a rechallenge (Fig. 3), in
terms of cell expansion and cell function (Fig. 3A, C, D, E). These
data argue that IL-7Ra and KLRG1 expression levels are
primarily controlled by the inflammatory environment encoun-
tered during priming, but do not reliably predict cell fate (i.e.
memory cell formation). The two memory populations produced
similar amounts of IFNc after rechallenge, but ‘‘DC only’’
memory cells tended to have a slightly higher percentage of IL-2
producing cells (Fig. 2 A, C). T cell autocrine IL-2 does not seem
to play a role in T cell differentiation [37], but has been correlated
with preferential effector cell survival in type I interferon driven
responses [5]. Whether the observed difference is physiologically
meaningful is unclear and potential consequences on cell fate and
function will require further investigation. Although functionally
similar, the ensuing two memory populations differed phenotyp-
ically whereby expression levels of CD27 and KLRG1 reflected
initial priming conditions even in tertiary memory populations
(Fig. 4A) that had been generated by rechallenge with a viral
pathogen (VSV-OVA). Memory cells that arose from minimal
effectors expressed less KLRG1 and more CD27 than memory
cells derived from effectors primed under inflammatory condi-
tions. We wanted to determine whether CD27 and KLRG1
expression could accurately predict the proliferative and functional
potential of memory cells. A positive correlation would have
suggested that the initial priming conditions could potentially
affect long-term memory fitness. Instead, we found that the
original phenotypic differences in the two effector populations
were still present in memory populations even 5 days after
rechallenging tertiary memory cells (i.e. quaternary memory):
memory cells derived from minimal effectors expressed less
KLRG1 and more CD27 (Fig. 4B), but expression levels of
KLRG1 and CD27 had no impact on the quality of the memory
response as measured by the ability to proliferate and clear a viral
infection (Fig. 4B, C). Together, these data suggest that KLRG1
and CD27 expression on memory cells can reflect the original
priming conditions, but do not predict memory cell fitness.
Clearly, acquisition of maximal effector function in the primary
response is not required to generate CD8 memory and to gain
maximal effector function after rechallenge, but how does this
insight impact our current approach to vaccination? One concern
about repeatedly stimulating T cells is that these cells can lose their
memory characteristics and are pushed towards an effector
Figure 3. The ability of CD8 memory T cells to mount a robust
recall response is independent of acquiring effector markers in
the primary response. (A) 40+ days after the primary response, mice
of both experimental groups were immunized with recombinant
vaccinia virus expressing Ova (Vacc-OVA) [40]. The OT-I memory T cell
response was analyzed 5 days later measuring T cell function (IFNc,
granzyme B) and (B) expansion. (C) 500 memory T cells (40+ days after
priming) were transferred into naı ¨ve hosts and (C) expansion and (D) T
cell function (IFNc, granzyme B) were determined 7 days after infection
with Vacc-OVA. (E) The OT-I memory T cell (40+ days after priming)
response in the lung was analyzed 5 days after challenge with Vacc-
OVA. The data shown are representative of 2 similar experiments with
3–5 animals per group.
doi:10.1371/journal.pone.0032576.g003
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replicative potential with each round of restimulation [12,16,38].
We found that memory cells were skewed towards an effector
memory phenotype and uniformly CD62L low prior to a
quaternary challenge (Fig. 4A), but still capable of robust
expansion when rechallenged (Fig. 4B), indicating that a loss of
proliferative potential is not characteristic of all prime boost
strategies. In summary, the protective ability and proliferative
potential of a memory T cell can be sustained even after several
rounds of prime-boost stimulation and memory cell fitness does
not correlate with currently used phenotypic markers.
Our data provide evidence that the initial priming conditions
are imprinted in memory T cells, even after several rounds of
restimulation. Thus, the initial priming conditions dictate aspects
of the memory phenotype, including the currently used markers
CD27 and KLRG1 of senescence. Our data show that these
markers are not suitable for predicting T cell fitness and a novel set
of biomarkers, ideally with known functional properties and
Figure 4. Acquisition of maximal effector function in the primary response correlates with a more senescent phenotype after a
recall response, but not with proliferative potential. C57BL/6 mice were injected intravenously (i.v.) with 1610
6 peptide pulsed DCs and
1610
4 naı ¨ve OT-I T cells with (DC+LM) or without (DC only) an accompanying Listeria monocytogenes infection. DC only and DC+LM mice received
another injection of DC only or DC+LM (2610
5 cfu) at least 30 days after priming, were rested for at least 30 days and then infected with VSV-OVA.
These tertiary memory OT-I T cells were transferred into new B6 hosts to examine their proliferative potential and ability to clear a vaccinia infection.
(A) OT-I phenotype before transfer of OT-I T cells into new B6 hosts. (B) OT-I numbers and phenotype 5 days after vaccinia infection. (C) Protective
ability as measured by vaccinia pfu in the ovaries. The data shown are representative of up to 10 (and at least 2) independent experiments with 2–5
animals per group.
doi:10.1371/journal.pone.0032576.g004
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and proliferative potential.
Materials and Methods
Ethics Statement
This study was approved by and all experiments were done in
accordance with the University of Washington Institutional
Animal Care and Use Committee (protocol number 2015-01).
The UW School of Medicine is fully accredited by the American
Association for Accreditation of Laboratory Animal care. An
Animal Welfare Assurance is on file with OPRR-NIH.
Mice
C57BL/6 and RAG KO mice were obtained from The Jackson
Laboratory (Bar Harbor, ME) and housed in specific pathogen-
free conditions in the animal facilities at the University of
Washington (Seattle, WA). OT-I TCR transgenic mice congenic
for CD45.1 or Thy1.1 were bred and maintained in the same
facilities.
Adoptive transfer and cell sorting
Naı ¨ve CD44
low OT-I T cells were isolated from lymph nodes as
previously described [20]. A total number of 1610
4 naı ¨ve OT-I T
cells per recipient was transferred. Transfer of memory cells:
splenic CD8 T cells were enriched by depleting CD4
+, CD19
+ and
I-Ab
+ cells in a magnetic column (Miltenyi) and a population of
CD8 T cells containing 500 or 1610
5 memory OT-I T cells was
injected into naı ¨ve recipients.
Dendritic cell isolation
Dendritic cells (DC) were expanded in B6 mice with a Flt-3L
secreting mouse melanoma cell line. CD11c
+ cells were purified,
LPS (1 mg/ml) and peptide (1 mg/ml) pulsed in vitro prior transfer
as previously described [20].
Infections
Listeria monocytogenes was grown as previously described [20]. For
primary infections, mice were injected i.v. with 2610
3 cfu LM,
previously infected mice received 2610
5 cfu LM. In some
experiments memory cells were boosted with a recombinant
VSV strain expressing the SIINFEKL epitope [39]. After transfer
of secondary or tertiary memory CD8 T cells, new recipient mice
were infected with 2610
6 pfu of a recombinant vaccinia strain
expressing the SIINFEKL epitope [40] and were sacrificed 5 to 7
days later. Vaccinia pfu was determined in ovaries of RAG mice 5
days post T cell transfer and infection.
Flow Cytometry
Recipient mice were sacrificed at the time points indicated. For
intracellular staining, cells were prepared with the Cytofix/
Cytoperm kit in the presence of brefeldin A (BD) and incubated
with or without 100 nM SIINFEKL peptide for 4–5 hours in
complete RP10. Cells were analyzed using a FACSCanto (BD)
and analyzed using FlowJo (TreeStar) software
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